Glucosamine Sulphate and Increased Level of Blood Cholesterol

This study has been completed.

Sponsors and Collaborators:	Slidgigtinstituttet Pharma Nord
Information provided by:	Slidgigtinstituttet
ClinicalTrials.gov Identifier:	NCT00251069

Purpose

Glucosamine sulphate causes no changes in blood levels of cholesterol

Condition	Intervention	Phase
Osteoarthritis	Drug: Glucosamine sulphate	Phase IV

Genetics Home Reference related topics: hypercholesterolemia

MedlinePlus related topics: Cholesterol Osteoarthritis

Study Type:	Interventional
Study Design:	Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Official Title:	Glucosamine Sulphate and Hypercholesterolaemia

Further study details as provided by Slidgigtinstituttet:

Primary Outcome Measures:

Secondary Outcome Measures:

Estimated Enrollment:	66
Study Start Date:	April 2005
Estimated Study Completion Date:	August 2005

Detailed Description:

The effects on glucosamine sulphate on blood levels of choleterol is measuered in patients with mild to moderate osteoarthritis

Eligibility

Criteria

Inclusion Criteria: Osteoarthritic pain, normal blood cholesterol levels -

Exclusion Criteria: Systemic diseases, pregnancy, need of medication besides painkillers

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00251069

Locations

Sponsors and Collaborators

Slidgigtinstituttet

Pharma Nord

Investigators

Principal Investigator:

Keld Ostergaard, M.D., Ph.D.

Slidgigtinstituttet

More Information

Study ID Numbers:	EudraCTnr 2005-000541-11
Study First Received:	November 7, 2005
Last Updated:	November 7, 2005
ClinicalTrials.gov Identifier:	NCT00251069
Health Authority:	Denmark: Lægemiddelstyrelsen (Danish Health Authorities)

Keywords provided by Slidgigtinstituttet:

glucosamine sulphate, osteoarthritis, cholesterol,

Study placed in the following topic categories:

Musculoskeletal Diseases
Osteoarthritis
Joint Diseases

Arthritis
Rheumatic Diseases
Hypercholesterolemia

ClinicalTrials.gov processed this record on January 16, 2009